{"id":555125,"date":"2026-04-20T01:00:00","date_gmt":"2026-04-19T23:00:00","guid":{"rendered":"https:\/\/medizinonline.com\/si-les-antihistaminiques-ne-suffisent-pas-et-que-les-ige-sont-faibles\/"},"modified":"2026-04-23T13:31:17","modified_gmt":"2026-04-23T11:31:17","slug":"si-les-antihistaminiques-ne-suffisent-pas-et-que-les-ige-sont-faibles","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/fr\/si-les-antihistaminiques-ne-suffisent-pas-et-que-les-ige-sont-faibles\/","title":{"rendered":"Si les antihistaminiques ne suffisent pas et que les IgE sont faibles"},"content":{"rendered":"\n<p><strong>L&#8217;urticaire chronique entra\u00eene souvent une grande souffrance, mais de nouvelles options th\u00e9rapeutiques sont en train d&#8217;\u00e9merger &#8211; depuis la publication des derni\u00e8res lignes directrices S3, les choses ont beaucoup \u00e9volu\u00e9. Le dupilumab, un autre m\u00e9dicament biologique, a re\u00e7u l&#8217;approbation de la FDA\/EMA pour le CSU, mais uniquement pour les patients na\u00effs d&#8217;omalizumab. Le remibrutinib, une &#8220;petite mol\u00e9cule&#8221;, a \u00e9galement franchi les obstacles de l&#8217;approbation aux \u00c9tats-Unis et de nouvelles donn\u00e9es sont disponibles pour les produits biologiques barzolvolimab et briquilimab. Pour choisir le traitement syst\u00e9mique de premi\u00e8re ligne appropri\u00e9, l&#8217;IgE totale gagne en importance en tant que biomarqueur pr\u00e9dictif.   <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fsi-les-antihistaminiques-ne-suffisent-pas-et-que-les-ige-sont-faibles%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;urticaire chronique entra\u00eene souvent une grande souffrance, mais de nouvelles options th\u00e9rapeutiques sont en train d&#8217;\u00e9merger &#8211; depuis la publication des derni\u00e8res lignes directrices S3, les choses ont beaucoup \u00e9volu\u00e9&#8230;.&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/fr\/mon-compte\/paquets\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/fr\/se-connecter\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Ffr%2Fsi-les-antihistaminiques-ne-suffisent-pas-et-que-les-ige-sont-faibles%2F\">Connectez-vous ici<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":555126,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Urticaire chronique : de nouvelles alternatives th\u00e9rapeutiques en vue  ","footnotes":"[{\"content\":\"p.ex. auto-immunit\\u00e9 de type I (auto-allergie), IgE contre les auto-antig\\u00e8nes et auto-immunit\\u00e9 de type IIb avec auto-anticorps activant les mastocytes\",\"id\":\"dbf840d8-1aae-45dd-b6a5-76477ae2aa5f\"}]"},"category":[11349,11362,11527,11464,11535,11549],"tags":[91556,14844,13449,13444,84837,72038,91555],"powerkit_post_featured":[],"class_list":["post-555125","post","type-post","status-publish","format-standard","has-post-thumbnail","category-allergologie-et-immunologie-clinique","category-dermatologie-et-venerologie","category-etudes","category-pharmacologie-et-toxicologie","category-rapports-de-congres","category-rx-fr","tag-alternatives-therapeutiques","tag-antihistaminique","tag-dupilumab-fr","tag-omalizumab-fr","tag-remibrutinib-fr","tag-urticaire-chronique","tag-valeurs-ige","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-05-01 01:41:17","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"fr_FR","wpml_translations":{"it_IT":{"locale":"it_IT","id":555122,"slug":"se-gli-antistaminici-non-sono-sufficienti-e-i-livelli-di-ige-sono-bassi","post_title":"Se gli antistaminici non sono sufficienti e i livelli di IgE sono bassi","href":"https:\/\/medizinonline.com\/it\/se-gli-antistaminici-non-sono-sufficienti-e-i-livelli-di-ige-sono-bassi\/"},"pt_PT":{"locale":"pt_PT","id":555119,"slug":"se-os-anti-histaminicos-nao-forem-suficientes-e-os-niveis-de-ige-forem-baixos","post_title":"Se os anti-histam\u00ednicos n\u00e3o forem suficientes e os n\u00edveis de IgE forem baixos","href":"https:\/\/medizinonline.com\/pt-pt\/se-os-anti-histaminicos-nao-forem-suficientes-e-os-niveis-de-ige-forem-baixos\/"},"es_ES":{"locale":"es_ES","id":555143,"slug":"si-los-antihistaminicos-no-son-suficientes-y-los-niveles-de-ige-son-bajos","post_title":"Si los antihistam\u00ednicos no son suficientes y los niveles de IgE son bajos","href":"https:\/\/medizinonline.com\/es\/si-los-antihistaminicos-no-son-suficientes-y-los-niveles-de-ige-son-bajos\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/comments?post=555125"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555125\/revisions"}],"predecessor-version":[{"id":555127,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/posts\/555125\/revisions\/555127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media\/555126"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/media?parent=555125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/category?post=555125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/tags?post=555125"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/fr\/wp-json\/wp\/v2\/powerkit_post_featured?post=555125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}